Thursday, September 17, 2026

BTC $76,554 ▲ 0.54%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.200+1.71%ETH$2,442+1.04%LINK$11.17+1.08%SOL$100.47+1.92%BTC$76,554+0.54%XRP$1.30+0.33%S&P 5007,552−0.45%Nasdaq25,978−0.01%Dow51,462−1.21%RUT2,859−0.40%TNX5.01%+0.20%TYX5.35%−0.28%FVX4.86%+0.68%IRX3.97%+0.25%VIX16.06−9.32%GOLD$4,346.40−0.94%SILVER$64.38−0.83%OIL$101.98−0.44%DXY100.17−0.08%NVDA$213.90+0.82%AAPL$332.41+0.32%TSLA$358.08+0.42%META$673.31+0.46%MSFT$490.30−1.37%AMZN$245.96−0.99%GOOGL$342.87−0.61%Fear & Greed50 — NeutralADA$0.200+1.71%ETH$2,442+1.04%LINK$11.17+1.08%SOL$100.47+1.92%BTC$76,554+0.54%XRP$1.30+0.33%S&P 5007,552−0.45%Nasdaq25,978−0.01%Dow51,462−1.21%RUT2,859−0.40%TNX5.01%+0.20%TYX5.35%−0.28%FVX4.86%+0.68%IRX3.97%+0.25%VIX16.06−9.32%GOLD$4,346.40−0.94%SILVER$64.38−0.83%OIL$101.98−0.44%DXY100.17−0.08%NVDA$213.90+0.82%AAPL$332.41+0.32%TSLA$358.08+0.42%META$673.31+0.46%MSFT$490.30−1.37%AMZN$245.96−0.99%GOOGL$342.87−0.61%Fear & Greed50 — Neutral

Tag

cancer treatment

1 article

Research & Analysis20d ago

Revolution Medicines' Rasonque Doubles Pancreatic Cancer Survival

Approval of the once-daily pill, which extended median survival from 6.7 months to 13 months in late-stage trials, values the company at $46 billion as it targets a previously untreatable protein mutation.